nach oben

Medical Oncology

Erschienen in:

01.07.2022 | Review Article

The functions, oncogenic roles, and clinical significance of circular RNAs in renal cell carcinoma

verfasst von: Hui Huang, Tao Chen, Fei Li, Dan Jin, Chuan Li, Yongbo Yang, Xuyang Liu, Dongmiao Wang, Jiehui Di

Erschienen in: Medical Oncology | Ausgabe 7/2022

Einloggen, um Zugang zu erhalten

Abstract

Renal cell carcinoma (RCC) is the most common form of malignancy affecting the kidneys. Circular RNAs (circRNAs) are non-coding RNAs that are derived from exonic or intronic sequences through a selective shearing process. There is growing evidence that these circRNAs can influence a range of biological pathways by serving as protein decoys, microRNA sponges, regulators of transcriptional activity, or templates for protein translation. The dysregulation of circRNA expression patterns is a hallmark of RCC and other cancer types, and there is strong evidence that these RNA species can play central roles in the onset and progression of RCC tumors. In the present review, we summarized recent findings on the functional roles and clinical impacts of circRNAs in RCC. Further, we discussed their potential utility as diagnostic biomarkers or targets for therapeutic intervention.

Wang Y, Zhang Y, Wang P, Fu X, Lin W. Circular RNAs in renal cell carcinoma: implications for tumorigenesis, diagnosis, and therapy. Mol Cancer. 2020;19(1):149.PubMedPubMedCentral

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA. 2020;70(1):7–30.PubMed

Wu W, Ji P, Zhao F. CircAtlas: an integrated resource of one million highly accurate circular RNAs from 1070 vertebrate transcriptomes. Genome Biol. 2020;21(1):101.PubMedPubMedCentral

Franz A, Ralla B, Weickmann S, Jung M, Rochow H, Stephan C, Erbersdobler A, Kilic E, Fendler A, Jung K. Circular RNAs in clear cell renal cell carcinoma: their microarray-based identification, analytical validation, and potential use in a clinico-genomic model to improve prognostic accuracy. Cancers. 2019;11(10):1473.PubMedCentral

Chen Q, Liu T, Bao Y, Zhao T, Wang J, Wang H, Wang A, Gan X, Wu Z, Wang L. CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway. Cancer Lett. 2020;469:68–77.PubMed

Huang Y, Zhang C, Xiong J, Ren H. Emerging important roles of circRNAs in human cancer and other diseases. Genes Dis. 2021;8(4):412–23.PubMed

Liu Z, Li M. Circular RNAs and their role in renal cell carcinoma: a current perspective. Cancer Cell Int. 2021;21(1):469.PubMedPubMedCentral

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2018;68(6):394–424.PubMed

Takyar S, Diaz J, Sehgal M, Sapunar F, Pandha H. First-line therapy for treatment-naive patients with advanced/metastatic renal cell carcinoma: a systematic review of published randomized controlled trials. Anticancer Drugs. 2016;27(5):383–97.PubMed

10.

Nisar S, Bhat AA, Singh M, Karedath T, Rizwan A, Hashem S, Bagga P, Reddy R, Jamal F, Uddin S, Chand G, Bedognetti D, El-Rifai W, Frenneaux MP, Macha MA, Ahmed I, Haris M. Insights into the role of CircRNAs: biogenesis, characterization, functional, and clinical impact in human malignancies. Front Cell Dev Biol. 2021;9:617281.PubMedPubMedCentral

11.

Li Z, Huang C, Bao C, Chen L, Lin M, Wang X, Zhong G, Yu B, Hu W, Dai L, Zhu P, Chang Z, Wu Q, Zhao Y, Jia Y, Xu P, Liu H, Shan G. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015;22(3):256–64.PubMed

12.

Rong D, Sun H, Li Z, Liu S, Dong C, Fu K, Tang W, Cao H. An emerging function of circRNA-miRNAs-mRNA axis in human diseases. Oncotarget. 2017;8(42):73271–81.PubMedPubMedCentral

13.

Gebert LFR, MacRae IJ. Regulation of microRNA function in animals. Nat Rev Mol Cell Biol. 2019;20(1):21–37.PubMedPubMedCentral

14.

Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, Loewer A, Ziebold U, Landthaler M, Kocks C, le Noble F, Rajewsky N. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333–8.PubMed

15.

Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–8.PubMed

16.

Liu J, Liu T, Wang X, He A. Circles reshaping the RNA world: from waste to treasure. Mol Cancer. 2017;16(1):58.PubMedPubMedCentral

17.

Yang Y, Fan X, Mao M, Song X, Wu P, Zhang Y, Jin Y, Yang Y, Chen LL, Wang Y, Wong CC, Xiao X, Wang Z. Extensive translation of circular RNAs driven by N(6)-methyladenosine. Cell Res. 2017;27(5):626–41.PubMedPubMedCentral

18.

Wang Y, Wang Z. Efficient backsplicing produces translatable circular mRNAs. RNA. 2015;21(2):172–9.PubMedPubMedCentral

19.

Chen CY, Sarnow P. Initiation of protein synthesis by the eukaryotic translational apparatus on circular RNAs. Science. 1995;268(5209):415–7.PubMed

20.

Legnini I, Di Timoteo G, Rossi F, Morlando M, Briganti F, Sthandier O, Fatica A, Santini T, Andronache A, Wade M, Laneve P, Rajewsky N, Bozzoni I. Circ-ZNF609 Is a circular RNA that can be translated and functions in myogenesis. Mol Cell. 2017;66(1):22–37.PubMedPubMedCentral

21.

Abe N, Matsumoto K, Nishihara M, Nakano Y, Shibata A, Maruyama H, Shuto S, Matsuda A, Yoshida M, Ito Y, Abe H. Rolling circle translation of circular RNA in living human cells. Sci Rep. 2015;5:16435.PubMedPubMedCentral

22.

Abe N, Hiroshima M, Maruyama H, Nakashima Y, Nakano Y, Matsuda A, Sako Y, Ito Y, Abe H. Rolling circle amplification in a prokaryotic translation system using small circular RNA. Angew Chem Int Ed Engl. 2013;52(27):7004–8.PubMed

23.

Ma C, Qin J, Zhang J, Wang X, Wu D, Li X. Construction and analysis of circular RNA molecular regulatory networks in clear cell renal cell carcinoma. Mol Med Rep. 2020;21(1):141–50.PubMed

24.

Xiong Y, Zhang J, Song C. CircRNA ZNF609 functions as a competitive endogenous RNA to regulate FOXP4 expression by sponging miR-138-5p in renal carcinoma. J Cell Physiol. 2019;234(7):10646–54.PubMed

25.

Xue D, Wang H, Chen Y, Shen D, Lu J, Wang M, Zebibula A, Xu L, Wu H, Li G, Xia L. Circ-AKT3 inhibits clear cell renal cell carcinoma metastasis via altering miR-296-3p/E-cadherin signals. Mol Cancer. 2019;18(1):151.PubMedPubMedCentral

26.

Gui CP, Liao B, Luo CG, Chen YH, Tan L, Tang YM, Li JY, Hou Y, Song HD, Lin HS, Xu QH, Yao GS, Yao HH, Xi L, Luo JH, Cao JZ, Wei JH. circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis. Mol Cancer. 2021;20(1):169.PubMedPubMedCentral

27.

Cen J, Liang Y, Huang Y, Pan Y, Shu G, Zheng Z, Liao X, Zhou M, Chen D, Fang Y, Chen W, Luo J, Zhang J. Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis. Mol Cancer. 2021;20(1):19.PubMedPubMedCentral

28.

Mao W, Wang K, Xu B, Zhang H, Sun S, Hu Q, Zhang L, Liu C, Chen S, Wu J, Chen M, Li W, Peng B. ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma. Mol Cancer. 2021;20(1):142.PubMedPubMedCentral

29.

Lv Q, Wang G, Zhang Y, Shen A, Tang J, Sun Y, Ma C, Wang P. CircAGAP1 promotes tumor progression by sponging miR-15-5p in clear cell renal cell carcinoma. J Exp Clin Cancer Res. 2021;40(1):76.PubMedPubMedCentral

30.

Feng J, Guo Y, Li Y, Zeng J, Wang Y, Yang Y, Xie G, Feng Q. Tumor promoting effects of circRNA_001287 on renal cell carcinoma through miR-144-targeted CEP55. J Exp Clin Cancer Res. 2020;39(1):269.PubMedPubMedCentral

31.

Li W, Yang FQ, Sun CM, Huang JH, Zhang HM, Li X, Wang GC, Zhang N, Che JP, Zhang WT, Yan Y, Yao XD, Peng B, Zheng JH, Liu M. circPRRC2A promotes angiogenesis and metastasis through epithelial-mesenchymal transition and upregulates TRPM3 in renal cell carcinoma. Theranostics. 2020;10(10):4395–409.PubMedPubMedCentral

32.

Kristensen LS, Okholm TLH, Veno MT, Kjems J. Circular RNAs are abundantly expressed and upregulated during human epidermal stem cell differentiation. RNA Biol. 2018;15(2):280–91.PubMed

33.

Han J, Meng J, Chen S, Wang X, Yin S, Zhang Q, Liu H, Qin R, Li Z, Zhong W, Zhang C, Zhang H, Tang Y, Lin T, Gao W, Zhang X, Yang L, Liu Y, Zhou HG, Sun T, Yang C. YY1 complex promotes quaking expression via super-enhancer binding during EMT of hepatocellular carcinoma. Cancer Res. 2019;79(7):1451–64.PubMed

34.

Rybak-Wolf A, Stottmeister C, Glazar P, Jens M, Pino N, Giusti S, Hanan M, Behm M, Bartok O, Ashwal-Fluss R, Herzog M, Schreyer L, Papavasileiou P, Ivanov A, Ohman M, Refojo D, Kadener S, Rajewsky N. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol Cell. 2015;58(5):870–85.PubMed

35.

Ottesen EW, Luo D, Seo J, Singh NN, Singh RN. Human survival motor neuron genes generate a vast repertoire of circular RNAs. Nucleic Acids Res. 2019;47(6):2884–905.PubMedPubMedCentral

36.

Yu J, Xu QG, Wang ZG, Yang Y, Zhang L, Ma JZ, Sun SH, Yang F, Zhou WP. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol. 2018;68(6):1214–27.PubMed

37.

Mao S, Zhang S, Zhou S, Huang T, Feng W, Gu X, Yu B. A Schwann cell-enriched circular RNA circ-Ankib1 regulates Schwann cell proliferation following peripheral nerve injury. FASEB J. 2019;33(11):12409–24.PubMedPubMedCentral

38.

Liu H, Hu G, Wang Z, Liu Q, Zhang J, Chen Y, Huang Y, Xue W, Xu Y, Zhai W. circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis. Theranostics. 2020;10(23):10791–807.PubMedPubMedCentral

39.

Mancuso M, Pazzaglia S, Tanori M, Hahn H, Merola P, Rebessi S, Atkinson MJ, Di Majo V, Covelli V, Saran A. Basal cell carcinoma and its development: insights from radiation-induced tumors in Ptch1-deficient mice. Cancer Res. 2004;64(3):934–41.PubMed

40.

Hasanovic A, Mus-Veteau I. Targeting the multidrug transporter Ptch1 potentiates chemotherapy efficiency. Cells. 2018;7(8):107.PubMedCentral

41.

Chen Z, Zheng Z, Xie Y, Zhong Q, Shangguan W, Zhang Y, Zhu D, Xie W. Circular RNA circPPP6R3 upregulates CD44 to promote the progression of clear cell renal cell carcinoma via sponging miR-1238-3p. Cell Death Dis. 2021;13(1):22.PubMedPubMedCentral

42.

Zheng Z, Chen Z, Zhong Q, Zhu D, Xie Y, Shangguan W, Xie W. CircPVT1 promotes progression in clear cell renal cell carcinoma by sponging miR-145-5p and regulating TBX15 expression. Cancer Sci. 2021;112(4):1443–56.PubMedPubMedCentral

43.

Xin R, Qu D, Xu H, Chen D. circ_001504 promotes the development of renal cell carcinoma by sponging microRNA-149 to increase NUCB2. Cancer Gene Ther. 2021;28(6):667–78.PubMed

44.

Zhang S, Zhu D, Li H, Li H, Feng C, Zhang W. Characterization of circRNA-associated-ceRNA networks in a senescence-accelerated mouse prone 8 brain. Mol Ther. 2017;25(9):2053–61.PubMedPubMedCentral

45.

Liu M, Shi X, Wang J, Xu Y, Wei D, Zhang Y, Yang K, Wang X, Liang S, Chen X, Yang F, Sun L, Zhu X, Zhao C, Zhu L, Tang L, Zheng C, Yang Z. Association of FOXP4 gene with prostate cancer and the cumulative effects of rs4714476 and 8q24 in Chinese men. Clin Lab. 2015;61(10):1491–9.PubMed

46.

Yang T, Li H, Thakur A, Chen T, Xue J, Li D, Chen M. FOXP4 modulates tumor growth and independently associates with miR-138 in non-small cell lung cancer cells. Tumour Biol. 2015;36(10):8185–91.PubMed

47.

Chen T, Yu Q, Shao S, Guo L. Circular RNA circFNDC3B protects renal carcinoma by miR-99a downregulation. J Cell Physiol. 2020;235(5):4399–406.PubMed

48.

Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science. 1997;276(5317):1423–5.PubMed

49.

Li J, Huang C, Zou Y, Yu J, Gui Y. Circular RNA MYLK promotes tumour growth and metastasis via modulating miR-513a-5p/VEGFC signalling in renal cell carcinoma. J Cell Mol Med. 2020;24(12):6609–21.PubMedPubMedCentral

50.

Li W, Song YY, Rao T, Yu WM, Ruan Y, Ning JZ, Yao XB, Yang SY, Cheng F. CircCSNK1G3 up-regulates miR-181b to promote growth and metastasis via TIMP3-mediated epithelial to mesenchymal transitions in renal cell carcinoma. J Cell Mol Med. 2021. https://doi.org/10.1111/jcmm.15911.CrossRefPubMedPubMedCentral

51.

Zhang D, Yang XJ, Luo QD, Fu DL, Li ZL, Zhang P, Chong T. Down-regulation of circular RNA_000926 attenuates renal cell carcinoma progression through miRNA-411-dependent CDH2 inhibition. Am J Pathol. 2019;189(12):2469–86.PubMed

52.

Alimperti S, Andreadis ST. CDH2 and CDH11 act as regulators of stem cell fate decisions. Stem Cell Res. 2015;14(3):270–82.PubMedPubMedCentral

53.

Huang S, Yang B, Chen BJ, Bliim N, Ueberham U, Arendt T, Janitz M. The emerging role of circular RNAs in transcriptome regulation. Genomics. 2017;109(5–6):401–7.PubMed

54.

Chen Z, Xiao K, Chen S, Huang Z, Ye Y, Chen T. Circular RNA hsa_circ_001895 serves as a sponge of microRNA-296-5p to promote clear cell renal cell carcinoma progression by regulating SOX12. Cancer Sci. 2020;111(2):713–26.PubMed

55.

Wang J, Zhang JQ, Zhao XL, Lu JY, Weng ZM, Ding ZM, Yang FQ. Circular RNA DHX33 promotes malignant behavior in ccRCC by targeting miR-489-3p/MEK1 axis. Aging. 2020;12(14):14885–96.PubMedPubMedCentral

56.

Fu J, Liu Y, Wang X, Yuan B, Zhang Y. Role of DHX33 in c-Myc-induced cancers. Carcinogenesis. 2017;38(6):649–60.PubMed

57.

Fang L, Ye T, An Y. Circular RNA FOXP1 induced by ZNF263 upregulates U2AF2 expression to accelerate renal cell carcinoma tumorigenesis and warburg effect through sponging miR-423-5p. J Immunol Res. 2021;2021:8050993.PubMedPubMedCentral

58.

Li J, Huang C, Zou Y, Ye J, Yu J, Gui Y. CircTLK1 promotes the proliferation and metastasis of renal cell carcinoma by sponging miR-136-5p. Mol Cancer. 2020;19(1):103.PubMedPubMedCentral

59.

Singh V, Jaiswal PK, Ghosh I, Koul HK, Yu X, De Benedetti A. Targeting the TLK1/NEK1 DDR axis with thioridazine suppresses outgrowth of androgen independent prostate tumors. Int J Cancer. 2019;145(4):1055–67.PubMedPubMedCentral

60.

De Benedetti A. The tousled-like kinases as guardians of genome integrity. ISRN Mol Biol. 2012;2012:627596.PubMedPubMedCentral

61.

Yan JS, Chen Q, Li YL, Gao YQ. Hsa_circ_0065217 promotes growth and metastasis of renal cancer through regulating the miR-214-3p-ALPK2 axis. Cell Cycle. 2021;20(23):2519–30.PubMed

62.

Yu R, Yao J, Ren Y. A novel circRNA, circNUP98, a potential biomarker, acted as an oncogene via the miR-567/ PRDX3 axis in renal cell carcinoma. J Cell Mol Med. 2020;24(17):10177–88.PubMedPubMedCentral

63.

Zeng J, Feng Q, Wang Y, Xie G, Li Y, Yang Y, Feng J. Circular RNA circ_001842 plays an oncogenic role in renal cell carcinoma by disrupting microRNA-502-5p-mediated inhibition of SLC39A14. J Cell Mol Med. 2020;24(17):9712–25.PubMedPubMedCentral

64.

Zhang X, Wang S, Wang H, Cao J, Huang X, Chen Z, Xu P, Sun G, Xu J, Lv J, Xu Z. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway. Mol Cancer. 2019;18(1):20.PubMedPubMedCentral

65.

Dong Z, Liu Y, Wang Q, Wang H, Ji J, Huang T, Khanal A, Niu H, Cao Y. The circular RNA-NRIP1 plays oncogenic roles by targeting microRNA-505 in the renal carcinoma cell lines. J Cell Biochem. 2020;121(3):2236–46.PubMed

66.

Lan Q, Peyvandi S, Duffey N, Huang YT, Barras D, Held W, Richard F, Delorenzi M, Sotiriou C, Desmedt C, Lorusso G, Ruegg C. Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer. Oncogene. 2019;38(15):2814–29.PubMed

67.

Chang LC, Fan CW, Tseng WK, Chein HP, Hsieh TY, Chen JR, Hwang CC, Hua CC. IFNAR1 is a predictor for overall survival in colorectal cancer and its mRNA expression correlated with IRF7 but not TLR9. Medicine. 2014;93(29):e349.PubMedPubMedCentral

68.

Lin L, Cai J. Circular RNA circ-EGLN3 promotes renal cell carcinoma proliferation and aggressiveness via miR-1299-mediated IRF7 activation. J Cell Biochem. 2020;121(11):4377–85.PubMed

69.

Lv Q, Ma C, Li H, Tan X, Wang G, Zhang Y, Wang P. Circular RNA microarray expression profile and potential function of circ0005875 in clear cell renal cell carcinoma. J Cancer. 2020;11(24):7146–56.PubMedPubMedCentral

70.

Huang Z, Ding Y, Zhang L, He S, Jia Z, Gu C, Wang T, Li H, Li X, Jin Z, Ding Y, Yang J. Upregulated circPDK1 promotes RCC cell migration and invasion by regulating the miR-377-3P-NOTCH1 axis in renal cell carcinoma. Onco Targets Ther. 2020;13:11237–52.PubMedPubMedCentral

71.

Liu Z, Wang R, Zhu G. Circ_0035483 functions as a tumor promoter in renal cell carcinoma via the miR-31-5p-mediated HMGA1 upregulation. Cancer Manage Res. 2021;13:693–706.

72.

Yue Y, Cui J, Zhao Y, Liu S, Niu W. Circ_101341 deteriorates the progression of clear cell renal cell carcinoma through the miR- 411/EGLN3 axis. Cancer Manage Res. 2020;12:13513–25.

73.

Zhao X, Zhao Z, Xu W, Liu H, Chang J, Xu W, Li S, Cao S, Hou J. Circ-SAR1A promotes renal cell carcinoma progression through miR-382/YBX1 axis. Cancer Manage Res. 2020;12:7353–61.

74.

Mo J, Zhao Y, Ao Z, Chen L, Lin S, Zeng W, Wu H, Liu J. Circ-APBB1IP as a prognostic biomarker promotes clear cell renal cell carcinoma progression through the ERK1/2 signaling pathway. Int J Med Sci. 2020;17(9):1177–86.PubMedPubMedCentral

75.

Zhu Q, Zhan D, Zhu P, Chong Y, Yang Y. CircAKT1 acts as a sponge of miR-338-3p to facilitate clear cell renal cell carcinoma progression by up-regulating CAV1. Biochem Biophys Res Commun. 2020;532(4):584–90.PubMed

76.

Sun J, Pan S, Cui H, Li H. CircRNA SCARB1 promotes renal cell carcinoma progression via Mir- 510–5p/SDC3 axis. Curr Cancer Drug Targets. 2020;20(6):461–70.PubMed

77.

Lai J, Xin J, Fu C, Zhang W. CircHIPK3 promotes proliferation and metastasis and inhibits apoptosis of renal cancer cells by inhibiting MiR-485-3p. Cancer Cell Int. 2020;20:248.PubMedPubMedCentral

78.

Zhou B, Zheng P, Li Z, Li H, Wang X, Shi Z, Han Q. CircPCNXL2 sponges miR-153 to promote the proliferation and invasion of renal cancer cells through upregulating ZEB2. Cell Cycle. 2018;17(23):2644–54.PubMedPubMedCentral

79.

Jin C, Shi L, Li Z, Liu W, Zhao B, Qiu Y, Zhao Y, Li K, Li Y, Zhu Q. Circ_0039569 promotes renal cell carcinoma growth and metastasis by regulating miR-34a-5p/CCL22. Am J Transl Res. 2019;11(8):4935–45.PubMedPubMedCentral

80.

Zhang L, Guo Y. Silencing circular RNA-ZNF652 represses proliferation and EMT process of renal carcinoma cells via raising miR-205. Artif Cells Nanomed Biotechnol. 2020;48(1):648–55.PubMed

81.

Yang CY, Wang J, Zhang JQ, Cai HM. Human circular RNA hsa_circRNA_101705 (circTXNDC11) regulates renal cancer progression by regulating MAPK/ERK pathway. Bioengineered. 2021;12(1):4432–41.PubMedPubMedCentral

82.

Yan L, Liu G, Cao H, Zhang H, Shao F. Hsa_circ_0035483 sponges hsa-miR-335 to promote the gemcitabine-resistance of human renal cancer cells by autophagy regulation. Biochem Biophys Res Commun. 2019;519(1):172–8.PubMed

83.

Li R, Luo S, Zhang D. Circular RNA hsa_circ_0054537 sponges miR-130a-3p to promote the progression of renal cell carcinoma through regulating cMet pathway. Gene. 2020;754:144811.PubMed

84.

Xiao H, Shi J. Exosomal circular RNA_400068 promotes the development of renal cell carcinoma via the miR2105p/SOCS1 axis. Mol Med Rep. 2020;22(6):4810–20.PubMedPubMedCentral

85.

Zhao YH, Wang Z, Zhang N, Cui T, Zhang YH. Effect of ciRS-7 expression on clear cell renal cell carcinoma progression. Chin Med J. 2020;133(17):2084–9.PubMedPubMedCentral

86.

Zhang G, Wang J, Tan W, Han X, Han B, Wang H, Xia Y, Sun Y, Li H. Circular RNA EGLN3 silencing represses renal cell carcinoma progression through the miR-1224–3p/HMGXB3 axis. Acta Histochem. 2021;123(6):151752.PubMed

87.

Luo S, Deng F, Yao N, Zheng F. Circ_0005875 sponges miR-502-5p to promote renal cell carcinoma progression through upregulating E26 transformation specific-1. Anticancer Drugs. 2022;33(1):e286–98.PubMed

88.

Zeng F, Luo L, Song M, Li D. Silencing of circular RNA PUM1 inhibits clear cell renal cell carcinoma progression through the miR-340–5p/FABP7 axis. J Recept Signal Transduct Res. 2021;2021:1–10.

89.

Huang Y, Zhang Y, Jia L, Liu C, Xu F. Circular RNA ABCB10 promotes tumor progression and correlates with pejorative prognosis in clear cell renal cell carcinoma. Int J Biol Markers. 2019;34(2):176–83.PubMed

90.

Han Z, Zhang Y, Sun Y, Chen J, Chang C, Wang X, Yeh S. ERbeta-mediated alteration of circATP2B1 and miR-204-3p signaling promotes invasion of clear cell renal cell carcinoma. Cancer Res. 2018;78(10):2550–63.PubMed

91.

Gong LJ, Wang XY, Yao XD, Wu X, Gu WY. CircESRP1 inhibits clear cell renal cell carcinoma progression through the CTCF-mediated positive feedback loop. Cell Death Dis. 2021;12(11):1081.PubMedPubMedCentral

92.

Jiao D, Huan Y, Zheng J, Wei M, Zheng G, Han D, Wu J, Xi W, Wei F, Yang AG, Qin W, Wang H, Wen W. UHRF1 promotes renal cell carcinoma progression through epigenetic regulation of TXNIP. Oncogene. 2019;38(28):5686–99.PubMed

93.

Dutta KK, Nishinaka Y, Masutani H, Akatsuka S, Aung TT, Shirase T, Lee WH, Yamada Y, Hiai H, Yodoi J, Toyokuni S. Two distinct mechanisms for loss of thioredoxin-binding protein-2 in oxidative stress-induced renal carcinogenesis. Lab Invest. 2005;85(6):798–807.PubMed

94.

Wang K, Sun Y, Tao W, Fei X, Chang C. Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) migration and invasion via altering the circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals. Cancer Lett. 2017;394:1–12.PubMed

95.

Chen T, Yu Q, Xin L, Guo L. Circular RNA circC3P1 restrains kidney cancer cell activity by regulating miR-21/PTEN axis and inactivating PI3K/AKT and NF- kB pathways. J Cell Physiol. 2020;235(4):4001–10.PubMed

96.

Wei X, Dong Y, Chen X, Ren X, Li G, Wang Y, Wang Y, Zhang T, Wang S, Qin C, Song N. Construction of circRNA-based ceRNA network to reveal the role of circRNAs in the progression and prognosis of metastatic clear cell renal cell carcinoma. Aging. 2020;12(23):24184–207.PubMedPubMedCentral

97.

Gao P, Huang Y, Hou Y, Li Q, Wang H. Circular RNA ITCH is a tumor suppressor in clear cell renal cell carcinoma metastasis through miR-106b-5p/PDCD4 axis. J Immunol Res. 2021;2021:5524344.PubMedPubMedCentral

98.

Wang G, Xue W, Jian W, Liu P, Wang Z, Wang C, Li H, Yu Y, Zhang D, Zhang C. The effect of Hsa_circ_0001451 in clear cell renal cell carcinoma cells and its relationship with clinicopathological features. J Cancer. 2018;9(18):3269–77.PubMedPubMedCentral

99.

Chen T, Shao S, Li W, Liu Y, Cao Y. The circular RNA hsa-circ-0072309 plays anti-tumour roles by sponging miR-100 through the deactivation of PI3K/AKT and mTOR pathways in the renal carcinoma cell lines. Artif Cells Nanomed Biotechnol. 2019;47(1):3638–48.PubMed

100.

Guo H, German P, Bai S, Barnes S, Guo W, Qi X, Lou H, Liang J, Jonasch E, Mills GB, Ding Z. The PI3K/AKT pathway and renal cell carcinoma. J Genet Genomics. 2015;42(7):343–53.PubMedPubMedCentral

101.

Sun J, Yin A, Zhang W, Lv J, Liang Y, Li H, Li Y, Li X. CircUBAP2 inhibits proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-148a-3p/FOXK2 pathway. Cell Transplant. 2020;29:963689720925751.PubMed

102.

Chen L, Wu D, Ding T. Circular RNA circ_0001368 inhibited growth and invasion in renal cell carcinoma by sponging miR-492 and targeting LATS2. Gene. 2020;753:144781.PubMed

103.

Cheng L, Cao H, Xu J, Xu M, He W, Zhang W, Dong L, Chen D. Circ_RPL23A acts as a miR-1233 sponge to suppress the progression of clear cell renal cell carcinoma by promoting ACAT2. J Bioenerg Biomembr. 2021;53(4):415–28.PubMed

104.

Li H, Heng B, Ouyang P, Xie X, Zhang T, Chen G, Chen Z, Cheang K, Lai C. Comprehensive profiling of circRNAs and the tumor suppressor function of circHIPK3 in clear cell renal carcinoma. J Mol Histol. 2020;51(3):317–27.PubMed

105.

Li K, Wan CL, Guo Y. Circular RNA circMTO1 suppresses RCC cancer cell progression via miR9/LMX1A axis. Technol Cancer Res Treat. 2020;19:1533033820914286.PubMedPubMedCentral

106.

Vo JN, Cieslik M, Zhang Y, Shukla S, Xiao L, Zhang Y, Wu YM, Dhanasekaran SM, Engelke CG, Cao X, Robinson DR, Nesvizhskii AI, Chinnaiyan AM. The landscape of circular RNA in cancer. Cell. 2019;176(4):869–81.PubMedPubMedCentral

107.

Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J, Chen D, Gu J, He X, Huang S. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015;25(8):981–4.PubMedPubMedCentral

108.

Bahn JH, Zhang Q, Li F, Chan TM, Lin X, Kim Y, Wong DT, Xiao X. The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva. Clin Chem. 2015;61(1):221–30.PubMed

109.

Li J, Sun D, Pu W, Wang J, Peng Y. Circular RNAs in cancer: biogenesis, function, and clinical significance, trends. Cancer. 2020;6(4):319–36.

110.

Chen YG, Kim MV, Chen X, Batista PJ, Aoyama S, Wilusz JE, Iwasaki A, Chang HY. Sensing self and foreign circular RNAs by intron identity. Mol Cell. 2017;67(2):228–38.PubMedPubMedCentral

111.

Zhang XL, Xu LL, Wang F. Hsa_circ_0020397 regulates colorectal cancer cell viability, apoptosis and invasion by promoting the expression of the miR-138 targets TERT and PD-L1. Cell Biol Int. 2017;41(9):1056–64.PubMed

112.

Ma Y, Zhang C, Zhang B, Yu H, Yu Q. circRNA of AR-suppressed PABPC1 91 bp enhances the cytotoxicity of natural killer cells against hepatocellular carcinoma via upregulating UL16 binding protein 1. Oncol Lett. 2019;17(1):388–97.PubMed

113.

Zhang Q, Wang W, Zhou Q, Chen C, Yuan W, Liu J, Li X, Sun Z. Roles of circRNAs in the tumour microenvironment. Mol Cancer. 2020;19(1):14.PubMedPubMedCentral

114.

Li J, Li Z, Jiang P, Peng M, Zhang X, Chen K, Liu H, Bi H, Liu X, Li X. Circular RNA IARS (circ-IARS) secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor metastasis. J Exp Clin Cancer Res. 2018;37(1):177.PubMedPubMedCentral

115.

Lee K, Hwang H, Nam KT. Immune response and the tumor microenvironment: how they communicate to regulate gastric cancer. Gut Liver. 2014;8(2):131–9.PubMedPubMedCentral

116.

Ma Z, Shuai Y, Gao X, Wen X, Ji J. Circular RNAs in the tumour microenvironment. Mol Cancer. 2020;19(1):8.PubMedPubMedCentral

117.

Peng X, Gao H, Xu R, Wang H, Mei J, Liu C. The interplay between HIF-1alpha and noncoding RNAs in cancer. J Exp Clin Cancer Res. 2020;39(1):27.PubMedPubMedCentral

118.

Liang G, Liu Z, Tan L, Su AN, Jiang WG, Gong C. HIF1alpha-associated circDENND4C promotes proliferation of breast cancer cells in hypoxic environment. Anticancer Res. 2017;37(8):4337–43.PubMed

119.

Su H, Zou D, Sun Y, Dai Y. Hypoxia-associated circDENND2A promotes glioma aggressiveness by sponging miR-625-5p. Cell Mol Biol Lett. 2019;24:24.PubMedPubMedCentral

120.

Ou ZL, Luo Z, Wei W, Liang S, Gao TL, Lu YB. Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis. RNA Biol. 2019;16(11):1592–603.PubMedPubMedCentral

121.

Dang RY, Liu FL, Li Y. Circular RNA hsa_circ_0010729 regulates vascular endothelial cell proliferation and apoptosis by targeting the miR-186/HIF-1alpha axis. Biochem Biophys Res Commun. 2017;490(2):104–10.PubMed

Titel: The functions, oncogenic roles, and clinical significance of circular RNAs in renal cell carcinoma
verfasst von: Hui Huang
Tao Chen
Fei Li
Dan Jin
Chuan Li
Yongbo Yang
Xuyang Liu
Dongmiao Wang
Jiehui Di
Publikationsdatum: 01.07.2022
Verlag: Springer US
Erschienen in: Medical Oncology / Ausgabe 7/2022
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI: https://doi.org/10.1007/s12032-022-01669-0

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

The functions, oncogenic roles, and clinical significance of circular RNAs in renal cell carcinoma

Abstract

Neu im Fachgebiet Onkologie

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

Update Onkologie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2022

Tumor-associated macrophages of the M1/M2 phenotype are involved in the regulation of malignant biological behavior of breast cancer cells through the EMT pathway

Decisions and dilemmas in non-metastatic castration-resistant prostate cancer management

20(s)-ginsenoside Rh2 promotes TRAIL-induced apoptosis by upregulating DR5 in human hepatocellular carcinoma cells

The Role of NRF2/KEAP1 Pathway in Glioblastoma: Pharmacological Implications

TMCO1 expression promotes cell proliferation and induces epithelial–mesenchymal transformation in human gliomas

PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer

Neu im Fachgebiet Onkologie

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

Update Onkologie